Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Firefly Neuroscience (AIFF) Cash from Financing Activities (2020 - 2025)

Historic Cash from Financing Activities for Firefly Neuroscience (AIFF) over the last 9 years, with Q3 2025 value amounting to -$19000.0.

  • Firefly Neuroscience's Cash from Financing Activities fell 10054.6% to -$19000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $13.2 million, marking a year-over-year increase of 10153.71%. This contributed to the annual value of $6.3 million for FY2024, which is 3566.66% up from last year.
  • As of Q3 2025, Firefly Neuroscience's Cash from Financing Activities stood at -$19000.0, which was down 10054.6% from $1.1 million recorded in Q2 2025.
  • Firefly Neuroscience's 5-year Cash from Financing Activities high stood at $10.3 million for Q1 2025, and its period low was -$87245.0 during Q2 2023.
  • In the last 5 years, Firefly Neuroscience's Cash from Financing Activities had a median value of $1.1 million in 2021 and averaged $2.1 million.
  • As far as peak fluctuations go, Firefly Neuroscience's Cash from Financing Activities soared by 8840184.0% in 2021, and later tumbled by 113962.11% in 2023.
  • Over the past 5 years, Firefly Neuroscience's Cash from Financing Activities (Quarter) stood at $8.9 million in 2021, then tumbled by 95.2% to $425000.0 in 2022, then skyrocketed by 404.94% to $2.1 million in 2023, then fell by 12.67% to $1.9 million in 2024, then tumbled by 101.01% to -$19000.0 in 2025.
  • Its Cash from Financing Activities stands at -$19000.0 for Q3 2025, versus $1.1 million for Q2 2025 and $10.3 million for Q1 2025.